We recently identified a novel NUP98-PHF23 fusinn in AML.
We recently identified a discriminating PC biomarker signature in a sporadic patient cohort.
On the losing end, we recently identified a set of non-U.S.
Background & Aims: We recently identified lysophosphatidic acid (LPA) as a potent antiapoptotic agent for the intestinal epithelium.
We recently identified mutants of the human FKBP12 protein that are unstable and rapidly degraded when expressed in mammalian cells.
We recently identified an ETD-like protein associated to S. aureus strains involved in mild mastitis in sheep.
We recently identified a chromone derivative, namely MBL-II-141 as a selective ABCG2 inhibitor, with relevant in vivo activity.
We recently identified five strong terminator regions (RPL41Bt, RPL15At, DIT1t, RPL3t, and IDP1t) in a comprehensive analysis of Saccharomyces cerevisiae.
We recently identified PDE8 as a novel target for inhibition of T cell chemotaxis [25].
We recently identified two additional Ub binding surfaces, both in the Josephin domain [17].
We recently identified Egr-1 as a novel intracellular mediator of TGF-β responses [10].
